Cargando…

Fasting Enhances the Contrast of Bone Metastatic Lesions in (18)F-Fluciclovine-PET: Preclinical Study Using a Rat Model of Mixed Osteolytic/Osteoblastic Bone Metastases

(18)F-fluciclovine (trans-1-amino-3-(18)F-fluorocyclobutanecarboxylic acid) is an amino acid positron emission tomography (PET) tracer used for cancer staging (e.g., prostate and breast). Patients scheduled to undergo amino acid-PET are usually required to fast before PET tracer administration. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oka, Shuntaro, Kanagawa, Masaru, Doi, Yoshihiro, Schuster, David M., Goodman, Mark M., Yoshimura, Hirokatsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454847/ https://www.ncbi.nlm.nih.gov/pubmed/28468238 http://dx.doi.org/10.3390/ijms18050934

Ejemplares similares

PET Tracer (18)F-Fluciclovine Can Detect Histologically Proven Bone Metastatic Lesions: A Preclinical Study in Rat Osteolytic and Osteoblastic Bone Metastasis Models
por: Oka, Shuntaro, et al.
Publicado: (2017)

Assessment of Amino Acid/Drug Transporters for Renal Transport of [(18)F]Fluciclovine (anti-[(18)F]FACBC) in Vitro
por: Ono, Masahiro, et al.
Publicado: (2016)

In Molecular Pursuit of Bone Metastasis by Fluciclovine PET
por: Lindenberg, Liza
Publicado: (2017)

Ra223 in Bone Metastases with Osteolytic Activity
por: Costa, Renato Patrizio, et al.
Publicado: (2018)

Hedgehog Signaling in Tumor Cells Facilitates Osteoblast-Enhanced Osteolytic Metastases
por: Das, Shamik, et al.
Publicado: (2012)

Bone Microenvironment‐Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in Mice
por: Arellano, Danna L., et al.
Publicado: (2022)

A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression
por: Cheng, Julia N., et al.
Publicado: (2021)

Differentiating Multiple Myeloma and Osteolytic Bone Metastases on Contrast-Enhanced Computed Tomography Scans: The Feasibility of Radiomics Analysis
por: Lee, Seungeun, et al.
Publicado: (2023)

Suppression of NADPH Oxidase Activity May Slow the Expansion of Osteolytic Bone Metastases
por: McCarty, Mark F., et al.
Publicado: (2016)

[(18)F]Fluciclovine PET discrimination between high- and low-grade gliomas
por: Parent, Ephraim E., et al.
Publicado: (2018)

BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation()()
por: Pan, Tianhong, et al.
Publicado: (2017)

[(18)F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis
por: Parent, Ephraim E., et al.
Publicado: (2020)

Radiation therapy combined with bone-modifying agents ameliorates local control of osteolytic bone metastases in breast cancer
por: Tanaka, Hidekazu, et al.
Publicado: (2020)

Effects of palliative radiotherapy and bisphosphonate usage on bone turnover marker levels in cancer patients with osteolytic bone metastases
por: Göksel, Fatih, et al.
Publicado: (2021)

Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone
por: Aldridge, S E, et al.
Publicado: (2005)

Atypical presentation of colorectal carcinoma with sole multiple osteolytic bone metastases: acase report
por: Kawamura, Ren, et al.
Publicado: (2021)

Specific bone region localization of osteolytic versus osteoblastic lesions in a patient-derived xenograft model of bone metastatic prostate cancer
por: Hirata, Takeshi, et al.
Publicado: (2016)

Semiquantitative assessment of osteoblastic, osteolytic, and mixed lytic-sclerotic bone lesions on fluorodeoxyglucose positron emission tomography/computed tomography and bone scintigraphy
por: Gurkan, Guray, et al.
Publicado: (2019)

Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts
por: Shupp, Alison B., et al.
Publicado: (2018)

Breast Cancer Cells Induce Osteolytic Bone Lesions In vivo through a Reduction in Osteoblast Activity in Mice
por: Gregory, Laura S., et al.
Publicado: (2013)

TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases
por: Drescher, Florian, et al.
Publicado: (2020)

Effect of glycosphingolipids on osteoclastogenesis and osteolytic bone diseases
por: Ersek, Adel, et al.
Publicado: (2012)

Arachnoid Granulations Mimicking Multiple Osteolytic Bone Lesions in the Occipital Bone
por: Park, Seong-Hyun, et al.
Publicado: (2018)

Osteoblastic bone metastases from renal cell carcinoma
por: Salapura, Vladka, et al.
Publicado: (2014)

Role of Tumor-Derived Chemokines in Osteolytic Bone Metastasis
por: Coniglio, Salvatore J.
Publicado: (2018)

Osteocyte CIITA aggravates osteolytic bone lesions in myeloma
por: Liu, Huan, et al.
Publicado: (2022)

A Pilot Study of F-18 Fluciclovine-PET/CT as a Diagnostic Tool for Bone Metastases in Patients With Castrate Resistant Prostate Adenocarcinoma and Correlative Analysis of Blood and Bone Molecular Testing (The FACT Study)
por: Babiker, Hani M, et al.
Publicado: (2023)

Bone Mass Changes Following Percutaneous Radiofrequency Ablation, Osteoplasty, Reinforcement, and Internal Fixation of Periacetabular Osteolytic Metastases
por: Jiang, Will, et al.
Publicado: (2023)

Osteoblastic Metastases Mimickers on Contrast Enhanced CT
por: Al-Lhedan, Fahad, et al.
Publicado: (2017)

A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions
por: Raheem, Omer, et al.
Publicado: (2011)

Tumor- and Osteoblast-Derived Periostin in Prostate Cancer bone Metastases
por: Sun, Chuan-Yu, et al.
Publicado: (2022)

F-18 Fluciclovine PET-CT Findings and Pseudoprogression on Immunotherapy
por: Poindexter, Bradley C, et al.
Publicado: (2022)

Bisphosphonate Treatment of Benign Multifocal and Unifocal Osteolytic Tumours of Bone
por: Gibbons, C. L. M. H., et al.
Publicado: (2003)

Melatonin Inhibits Osteoclastogenesis and Osteolytic Bone Metastasis: Implications for Osteoporosis
por: MacDonald, Iona J., et al.
Publicado: (2021)

The SK-N-AS human neuroblastoma cell line develops osteolytic bone metastases with increased angiogenesis and COX-2 expression
por: Tsutsumimoto, Takahiro, et al.
Publicado: (2014)

PTH1R-CaSR Cross Talk: New Treatment Options for Breast Cancer Osteolytic Bone Metastases
por: Yang, Yanmei, et al.
Publicado: (2018)

(18)F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review
por: Rais-Bahrami, Soroush, et al.
Publicado: (2021)

Osteolytic cancer cells induce vascular/axon guidance processes in the bone/bone marrow stroma
por: Hensel, Janine, et al.
Publicado: (2018)

Detection of Recurrent Prostate Cancer With (18)F-Fluciclovine PET/MRI
por: Selnæs, Kirsten Margrete, et al.
Publicado: (2020)

Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts
por: Shiirevnyamba, A, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_koee4slkdi09fnpi25kd1pm43f